Chopra says Linde/Praxair remedy not enough
The Federal Trade Commission should not have allowed the Linde/Praxair merger to go forward, a Democratic commissioner has said, criticising the proposed remedies and calling for the FTC to look harder at private equity buyers of divested assets.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10